Stifel maintains Buy rating and $66 target on GXO Logistics stock

Published 08/05/2025, 15:56
Stifel maintains Buy rating and $66 target on GXO Logistics stock

On Thursday, Stifel analysts maintained a Buy rating and a $66.00 price target for GXO Logistics Inc. (NYSE: GXO) stock, representing a potential 67% upside from the current price of $39.46. The logistics company, with a market capitalization of $4.46 billion, reported its first quarter earnings for 2025, with an adjusted EPS of $0.29, surpassing both the consensus estimate of $0.25 and Stifel’s own forecast of $0.26. According to InvestingPro analysis, the stock is currently trading below its Fair Value. In a climate where many companies are revising forecasts, GXO Logistics stood out by reaffirming its guidance for the full year.

The analysts pointed out that concerns which had previously impacted the stock, such as contract realignments in the fourth quarter of 2024 and the pending approval of the acquisition of Wincanton, are expected to be resolved shortly. The increased exposure to the European market, once considered a potential risk, is now seen as a beneficial factor for the company’s growth strategy.

The recent contract award from the National Health Service (NHS) in the United Kingdom (TADAWUL:4280) is anticipated to enhance GXO Logistics’ expansion into the healthcare sector. Stifel continues to view GXO as an attractive Growth at a Reasonable Price (GARP) investment opportunity over the medium term, citing the company’s solid performance and strategic initiatives.

In other recent news, GXO Logistics reported its first-quarter 2025 earnings, exceeding analyst expectations with an earnings per share (EPS) of $0.29, surpassing the forecast of $0.25. The company also outperformed revenue projections, reporting $3 billion against the anticipated $2.93 billion, marking a 21% year-over-year increase. GXO Logistics is currently focusing on the successful integration of its Wincanton acquisition and advancements in AI and automation technologies to drive future growth. The company has projected organic revenue growth between 3% and 6% for the full year 2025, with adjusted EBITDA expected to range from $840 million to $860 million.

GXO Logistics has also been recognized for its efforts in the healthcare sector, finalizing a significant contract with the UK National Health Services supply chain, which carries a lifetime value of about $2.5 billion. The ongoing integration of Wincanton is expected to yield $58 million in cost synergies. Despite macroeconomic pressures and potential tariffs, GXO Logistics remains confident in its business model, which is designed to provide flexibility and resilience. The company has also been named to the Forbes Diamond List in Poland and listed as a top 500 employer in the UK by the Financial Times.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.